By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Epigenomics AG 

Kleine Präsidentenstraße 1

Berlin    D-10178  Germany
Phone: 49-30-24-34-5-0 Fax: +49-30-24-34-55-55



Company News
Epigenomics AG Announces Q2 2015 And 6M 2015 Financial Results And Reports On Operational Highlights 8/6/2015 8:45:27 AM
Epigenomics AG And BioChain Announce The Inclusion Of their Proprietary Blood-based Septin9 Test In The Chinese Screening Guideline For Colorectal Cancer 7/15/2015 10:29:24 AM
Epigenomics AG Announces Q1 2015 Financial Results And Reports On Operational Highlights 5/12/2015 11:18:48 AM
Epigenomics AG Reaches 99.5 % Adherence for Epi proColon in ADMIT Study 5/8/2015 7:20:52 AM
Epigenomics AG Receives EUR 2.8 Million Grant For Validation Of Lung Cancer Biomarkers In Blood Plasma 4/29/2015 9:49:50 AM
Epigenomics AG Reports Results For The Financial Year Ended December 31, 2014 And Provides Outlook For 2015 3/25/2015 1:50:17 PM
Epigenomics AG Announces Completion Of Enrollment In Epi proColon ADMIT Trial 3/25/2015 10:01:40 AM
First Patients Enrolled In Epigenomics AG’ Epi proColon® ADMIT Study 12/17/2014 1:09:07 PM
Epigenomics AG To Present At Oppenheimer 25th Annual Healthcare Conference 12/10/2014 1:05:55 PM
Epigenomics AG And BioChain Announce Approval Of Epi proColon® In China 12/8/2014 2:09:18 PM